Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual

Our previous case‐control study observed isolated lymphocytes from 208 individuals and determined the differences in the sensitivity to genomic damage of lymphocytes derived from cancer patients, pre/suspect cancer patients and healthy volunteers using the Comet assay (Anderson et al, 2014). We adap...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Diana, Najafzadeh, Mojgan, Scally, Andrew, Jacob, Badie, Griffith, John, Chaha, Rohit, Linforth, Richard, Soussaline, Michel, Soussaline, Francoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996311/
https://www.ncbi.nlm.nih.gov/pubmed/32123810
http://dx.doi.org/10.1096/fba.1020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996311/
https://www.ncbi.nlm.nih.gov/pubmed/32123810
http://dx.doi.org/10.1096/fba.1020

Ejemplares similares